Home LiteratureArticle Details
PMID: 10081230 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

The Fas counterattack: cancer as a site of immune privilege.

Immunology today ·Vol. 20 ·No. 1 ·1999-01-00 ·Pages 46-52

O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F

Abstract

暂无摘要

MeSH Terms
Apoptosis Fas Ligand Protein Immune Tolerance Immunologic Surveillance Immunotherapy Inflammation Lymphocyte Activation Membrane Glycoproteins/physiology Models, Immunological Neoplasm Proteins/physiology Neoplasms/immunology,pathology Polymorphism, Genetic T-Lymphocytes/immunology,pathology fas Receptor/physiology
Chemicals
Fas Ligand Protein Membrane Glycoproteins Neoplasm Proteins fas Receptor
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
O'Connell J
Dept of Medicine, Cork University Hospital, Ireland. J.OConnell@ucc.ie
Bennett M W
O'Sullivan G C
Collins J K
Shanahan F
Article Info
Journal
Immunology today
Abbr.
Immunol Today
ISSN
0167-5699
DOI
10.1016/s0167-5699(98)01382-6
Email
j.oconnell@ucc.ie
Published
1999-01-00
Pages
46-52
Language
English
Region
England
NLM ID
8008346
Subset
IM
External Links
PubMed source DOI: 10.1016/s0167-5699(98)01382-6
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2